精确瘤学时代与乳腺癌相关的差异的生物学基础
Anca-Narcisa Neagu1, Pathea Bruno2, Kaya R Johnson2
1Laboratory of Animal Histology, Faculty of Biology, "Alexandru Ioan Cuza" University of Iași, Carol I bvd. 20A, 700505 Iasi, Romania.
International journal of molecular sciences
|April 13, 2024
概括
瘤乳腺学揭示了不同人群乳腺癌 (BC) 的分子差异. 了解这些差异是开发个性化治疗和减少BC发病率和死亡率的关键.
科学领域:
- 生物医学科学 生物医学科学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 精确瘤学依赖于瘤分子概况来进行个性化治疗.
- 乳腺癌 (BC) 的差异与种族,年龄,环境和获得医疗保健有关.
- 正在发现具有种族和种族差异的新生物标志物.
研究的目的:
- 从生物医学角度深入了解与BC相关的差异.
- 探索基因组,蛋白质组,表观组,激素组,代谢组和暴露组的因素.
- 研究瘤生物学,免疫和代谢景观以及生态/微生物组因素的差异.
主要方法:
- 审查关于BC差异的现有文献.
- 分析与瘤生物学相关的基因组和分子数据.
- 整合了曝光学,微生物学和元基因组学数据.
主要成果:
- 瘤乳腺学识别了具有显著种族和民族差异的生物标志物.
- 多种生物过程和分子途径有助于BC差异.
- 在患者群体之间观察到发病率,死亡率和治疗反应的差异.
结论:
- 瘤乳腺学为了解BC差异提供了一个框架.
- 这种方法可以澄清分子差异导致BC的差异.
- 通过解决这些已识别的差异,可以改进个性化治疗策略.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


